Purchase of 23 270-0173-001X implants and 28 270-0173-001 implants.
Ended Awarded Last action
- Contract number
- HT942525F0234
- Awardee
-
Harvard Bioscience Inc. UEI MUGFN52A5NJ1 Part of Harvard Bioscience Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $201,453
Award facts
- Contract value 100% obligated
- $201,453.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- ABER PROV GRD, MD 21010, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $201,453 firm fixed-price call order to Harvard Bioscience Inc. (operating as Data Sciences International) on July 15, 2025, for the purchase of 23 units of 270-0173-001X implants and 28 units of 270-0173-001 implants, with an ultimate completion date of August 15, 2025. The contract was executed without a set-aside designation and specifies performance at Aberdeen Proving Ground, Maryland. This call order is issued under Harvard Bioscience's existing $4.8 million blanket purchase agreement with the Defense Health Agency, which was awarded on May 4, 2022, and remains active through May 3, 2027.
Harvard Bioscience, a self-certified small disadvantaged business headquartered in New Brighton, Minnesota, specializes in advanced biomedical research equipment including implantable telemetry devices and physiological monitoring systems. The company serves as a critical supplier to the Defense Health Agency and Army Medical Command for specialized research instrumentation supporting preclinical and medical research programs across the military health system. Under the existing BPA vehicle, Harvard Bioscience has generated over $1.5 million in cumulative task order value, with the Defense Health Agency and Army Medical Command being the primary issuing agencies for call orders supporting diverse biomedical research requirements.
Quick answers
Who was awarded contract HT942525F0234?
HT942525F0234 was awarded to Harvard Bioscience Inc. by Defense Health Agency (Department of Defense) on July 15, 2025.
How much is contract HT942525F0234 worth?
The government has obligated $201,453 on HT942525F0234.
Is contract HT942525F0234 an order under another contract?
Yes. HT942525F0234 is a BPA call under W81XWH22A0001, a blanket purchase agreement.
Was contract HT942525F0234 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award